Brontictuzumab (Anti-NOTCH1)
Brontictuzumab (Anti-NOTCH1) (A2681-GRP)
Products
Description
Brontictuzumab (Anti-NOTCH1) is a monoclonal antibody that targets Notch1 signal. It inhibits tumor cell proliferation and can be used in the research of leukemia and lymphoma. MW :150 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2681 |
| Target | Notch |